ANALYSIS OF HETEROGENEITY IN DAUNORUBICIN UPTAKE BY HUMAN-LEUKEMIA CELLS USING LASER FLOW-CYTOMETRY

被引：0
作者：
GANAPATHI, R
GULICK, P
MILLER, R
GRABOWSKI, D
TURINIC, R
VALEUNZUELA, R
FISHLEDER, A
BUKOWSKI, R
机构：
来源：
INVESTIGATIONAL NEW DRUGS | 1985年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：273 / 277
页数：5
相关论文
共 15 条
[1]   CLINICAL AND PHARMACOLOGICAL IMPLICATIONS OF CANCER CELL-DIFFERENTIATION AND HETEROGENEITY [J].
CALABRESI, P ;
DEXTER, DL ;
HEPPNER, GH .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) :1933-1941
[2]   ADRIAMYCIN - REVIEW [J].
CARTER, SK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) :1265-1274
[3]   CHEMOTHERAPY OF ACUTE-LEUKEMIA - COMPARISON OF VINCRISTINE, CYTARABINE, AND PREDNISONE ALONE AND IN COMBINATION WITH CYCLOPHOSPHAMIDE OR DAUNORUBICIN [J].
COLTMAN, CA ;
BODEY, GP ;
HEWLETT, JS ;
HAUT, A ;
BICKERS, J ;
BALCERZAK, SP ;
COSTANZI, JJ ;
FREIREICH, EJ ;
MCCREDIE, KB ;
GROPPE, C ;
SMITH, TL ;
GEHAN, EA .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (09) :1342-1348
[4]  
DANO K, 1976, ACTA PATHOL MICRA SN, V256, P11
[5]   CORRELATION BETWEEN POTENCY OF CALMODULIN INHIBITORS AND EFFECTS ON CELLULAR-LEVELS AND CYTO-TOXIC ACTIVITY OF DOXORUBICIN (ADRIAMYCIN) IN RESISTANT P388 MOUSE LEUKEMIA-CELLS [J].
GANAPATHI, R ;
GRABOWSKI, D ;
TURINIC, R ;
VALENZUELA, R .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06) :799-806
[6]  
GANAPATHI R, 1982, J NATL CANCER I, V68, P1027
[7]  
Henderson E, 1983, LEUKEMIA, P575
[8]   UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA [J].
INABA, M ;
JOHNSON, RK .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (17) :2123-2130
[9]  
PREISLER HD, 1982, BLOOD CELLS, V8, P585
[10]  
RAZA A, 1982, P AM ASSOC CANC RES, V23, P175
12